Predictors of Blood Pressure Reduction With Nocturnal Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea and Prehypertension
Restricted accessResearch articleFirst published online February, 2014
Predictors of Blood Pressure Reduction With Nocturnal Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea and Prehypertension
Previous studies showed that treatment of obstructive sleep apnea syndrome (OSAS) with continuous positive airway pressure (CPAP) significantly reduced the blood pressure (BP) in hypertensive patients. We investigated the predictors of BP change in normotensive patients with OSAS who underwent CPAP. A total of 24 patients with OSAS (19 male; age: 48.7 ± 10.4 years) were enrolled. The 24-hour mean BP (24 hMBP), subjective sleepiness, fasting venous blood samples, and anthropometric measurements were assessed at baseline, 6th week and 12th week of CPAP treatment. The 24 hMBP fell at 12 weeks from 89.2 ± 8.4 to 82.9 ± 7.3 mm Hg (P < .0001) irrespective of the severity of disease. Also, both daytime and nighttime BP showed significant reduction after CPAP. Male gender, Epworth sleepiness scale, body mass index, smoking, alcohol use, and baseline 24 hMPB were the independent predictors of a fall in 24 hMBP. The CPAP therapy may provide benefit even in the absence of overt hypertension by reducing both daytime and nighttime BP.
YoungTPaltaMDempseyJSkatrudJWeberSBadrS. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–1235.
2.
PeppardPEYoungTPaltaMSkatrudJ. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–1384.
3.
GroteLHednerJPeterJH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000;18(6):679–685.
4.
IpMChungKFChanKNLamSPLeeK. Previously unrecognized obstructive sleep apnea in Chinese subjects with essential hypertension. Lung. 1999;177(6):391–400.
5.
KapaSSert KuniyoshiFHSomersVK. Sleep apnea and hypertension: interactions and implications for management. Hypertension. 2008;51(3):605–608.
6.
MillmanRPRedlineSCarlisleCCAssafARLevinsonPD. Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors. Chest. 1991;99(4):861–866.
7.
SeriesFCormierYLaforgeJ. Influence of continuous positive airway pressure on sleep apnea-related desaturation in sleep apnea patients. Lung. 1992;170(5):281–290.
8.
PatelSRWhiteDPMalhotraAStanchinaMLAyasNT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163(5):565–571.
9.
HednerJDarpoBEjnellHCarlsonJCaidahlK. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 1995;8(2):222–229.
10.
SchulzRMahmoudiSHattarK. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162(2 Pt 1):566–570.
11.
KraicziHCaidahlKSamuelssonAPekerYHednerJ. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest. 2001;119(4):1085–1091.
12.
DernaikaTAKinasewitzGTTawkMM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med. 2009;5(2):103–107.
13.
LoganAGTkacovaRPerlikowskiSM. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003;21(2):241–247.
14.
HaentjensPVan MeerhaegheAMoscarielloA. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167(8):757–764.
15.
AlajmiMMulgrewATFoxJ. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung. 2007;185(2):67–72.
16.
DragerLFPedrosaRPDinizPM. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension. 2011;57(3):549–555.
17.
ChobanianAVBakrisGLBlackHR. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252.
18.
ManciaGDe BackerGDominiczakA. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462–1536.
19.
DaskalopoulouSSKhanNAQuinnRR. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2012;28(3):270–287.
20.
RechtschaffenAKalesA. A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Los Angeles, CA: Brain Information Service/Brain Research Institute, University of California (UCLA); 1968.
21.
VasanRSLarsonMGLeipEP. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291–1297.
22.
AkashibaTMinemuraHYamamotoHKosakaNSaitoOHorieT.Nasal continuous positive airway pressure changes blood pressure “non-dippers” to “dippers” in patients with obstructive sleep apnea. Sleep. 1999;22(7):849–853.
23.
HigashiYNakagawaKKimuraM. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol. 2002;40(11):2039–2043.
24.
CicconeMMFavaleSScicchitanoP. Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol. 2012;158(3):383–386.
25.
AbateGD'AndreaLBattestiniMZitoMDi IorioA. Autonomic nervous activity in elderly dipper and non-dipper patients with essential hypertension. Aging (Milano). 1997;9(6):408–414.
26.
RagotSHerpinDSicheJPIngrandPMallionJM. Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences?J Hypertens. 1999;17(12 Pt 2):1805–1811.
27.
SherwoodASteffenPRBlumenthalJAKuhnCHinderliterAL. Nighttime blood pressure dipping: the role of the sympathetic nervous system. Am J Hypertens. 2002;15(2 Pt 1):111–118.
28.
RobinsonGVLangfordBASmithDMStradlingJR. Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). Thorax. 2008;63(10):855–859.
29.
HuiDSToKWKoFW. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax. 2006;61(12):1083–1090.
30.
PeledNKassirerMShitritD. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respiratory Med. 2007;101(8):1696–1701.
31.
ParishJMAdamTFacchianoL. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007;3(5):467–472.
32.
KostapanosMSElisafMSMikhailidisDP. Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link?Angiology. 2012;63(8):569–573.
33.
SopkovaZBerneisKRizzoM. Size and subclasses of low-density lipoproteins in patients with obstructive sleep apnea. Angiology. 2012;63(8):617–621.
34.
CuhadarogluCUtkusavasAOzturkLSalmanSEceT. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009;187(2):75–81.
35.
DorkovaZPetrasovaDMolcanyiovaAPopovnakovaMTkacovaR. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008;134(4):686–692.
36.
WolkRShamsuzzamanASSomersVK. Obesity, sleep apnea, and hypertension. Hypertension. 2003;42(6):1067–1074.
